Skip to Content

Immunotech Laboratories Inc - Stock Quote IMMB

Rating as of

Morningstar's Immunotech Laboratories Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics - IMMB

Immunotech Laboratories Inc's Company Profile

Business Description

Immunotech Laboratories Inc. is an organization with full indefinite licensing rights of the Irreversible Pepsin Fraction peptide molecule for the specific treatment and preventing of the HIV/AIDS indication.

116 W. Stocker Street
Glendale, CA, 91202
T +1 818 409-9091
Industry Biotechnology
Most Recent Earnings Sep 30, 2006
Fiscal Year End Dec 31, 2012
Stock Type Distressed
Employees 4